[
  {
    "id": 1,
    "repeat_id": 1,
    "question": "What prognostic factors were analyzed in relation to disease-free survival and overall survival in node-positive patients?",
    "answer": "According to the provided context, the following prognostic factors were analyzed: number of positive nodes, HER-2/neu, log (pgr), tumor size, age, and ER (estrogen receptor) status. These factors were evaluated using univariate and multivariate analyses to determine their relationship with disease-free survival and overall survival in node-positive patients.",
    "ground_truth": "The excerpt indicates that the prognostic factors analyzed include the number of positive nodes and HER-2/neu status. Specifically, the paper states: 'number of positive nodes 0. 0001 0. 0002' and 'her - 2 / neu 0. 0011 < 0. 0001'. This demonstrates that both factors are statistically significant in predicting survival outcomes.",
    "source": "'number of positive nodes 0. 0001 0. 0002 her - 2 / neu 0. 0011 < 0. 0001'",
    "difficulty": "hard",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:47:53",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 5.787034273147583
  },
  {
    "id": 1,
    "repeat_id": 2,
    "question": "What prognostic factors were analyzed in relation to disease-free survival and overall survival in node-positive patients?",
    "answer": "The prognostic factors analyzed included number of positive nodes, HER-2/neu amplification, log (pgr), tumor size, age, and ER status. These factors were evaluated using univariate and multivariate analyses to determine their impact on disease-free survival and overall survival in node-positive patients.",
    "ground_truth": "The excerpt indicates that the prognostic factors analyzed include the number of positive nodes and HER-2/neu status. Specifically, the paper states: 'number of positive nodes 0. 0001 0. 0002' and 'her - 2 / neu 0. 0011 < 0. 0001'. This demonstrates that both factors are statistically significant in predicting survival outcomes.",
    "source": "'number of positive nodes 0. 0001 0. 0002 her - 2 / neu 0. 0011 < 0. 0001'",
    "difficulty": "hard",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:47:56",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.566237211227417
  },
  {
    "id": 1,
    "repeat_id": 3,
    "question": "What prognostic factors were analyzed in relation to disease-free survival and overall survival in node-positive patients?",
    "answer": "The prognostic factors analyzed included number of positive nodes, HER-2/neu amplification, log (pgr), tumor size, age, and ER status. These factors were evaluated using univariate and multivariate analyses to determine their relationship with disease-free survival and overall survival in node-positive patients.",
    "ground_truth": "The excerpt indicates that the prognostic factors analyzed include the number of positive nodes and HER-2/neu status. Specifically, the paper states: 'number of positive nodes 0. 0001 0. 0002' and 'her - 2 / neu 0. 0011 < 0. 0001'. This demonstrates that both factors are statistically significant in predicting survival outcomes.",
    "source": "'number of positive nodes 0. 0001 0. 0002 her - 2 / neu 0. 0011 < 0. 0001'",
    "difficulty": "hard",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:48:00",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.7173821926116943
  },
  {
    "id": 2,
    "repeat_id": 1,
    "question": "What potential therapeutic implications are suggested by the identification of the ligand in breast cancer?",
    "answer": "The identification of the ligand for HER-2/neu could have important therapeutic implications, including the development of specific antagonists to target this receptor. This could potentially lead to new treatments for breast cancer.",
    "ground_truth": "The identification of its ligand and the development of specific antagonists could have important therapeutic implications. Specifically, the paper states: 'identification of its ligand and development of specific antagonists could have important therapeutic implications.' This demonstrates that targeting the ligand may lead to new treatment strategies for breast cancer.",
    "source": "identification of its ligand and development of specific antagonists could have important therapeutic implications.",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:48:03",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.1596012115478516
  },
  {
    "id": 2,
    "repeat_id": 2,
    "question": "What potential therapeutic implications are suggested by the identification of the ligand in breast cancer?",
    "answer": "The identification of the ligand for HER-2/neu suggests that developing specific antagonists could have important therapeutic implications, potentially leading to new treatments for breast cancer. This could help in targeting and inhibiting the growth of cancer cells expressing this receptor.",
    "ground_truth": "The identification of its ligand and the development of specific antagonists could have important therapeutic implications. Specifically, the paper states: 'identification of its ligand and development of specific antagonists could have important therapeutic implications.' This demonstrates that targeting the ligand may lead to new treatment strategies for breast cancer.",
    "source": "identification of its ligand and development of specific antagonists could have important therapeutic implications.",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:48:06",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.2144341468811035
  },
  {
    "id": 2,
    "repeat_id": 3,
    "question": "What potential therapeutic implications are suggested by the identification of the ligand in breast cancer?",
    "answer": "The study suggests that identifying the ligand for HER-2/neu could lead to the development of specific antagonists, which could have important therapeutic implications for breast cancer treatment. This could potentially inhibit the growth of cancer cells expressing this receptor.",
    "ground_truth": "The identification of its ligand and the development of specific antagonists could have important therapeutic implications. Specifically, the paper states: 'identification of its ligand and development of specific antagonists could have important therapeutic implications.' This demonstrates that targeting the ligand may lead to new treatment strategies for breast cancer.",
    "source": "identification of its ligand and development of specific antagonists could have important therapeutic implications.",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:48:09",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.203437089920044
  },
  {
    "id": 3,
    "repeat_id": 1,
    "question": "What is the significance of the her-2/neu oncogene in human breast cancer as discussed in the excerpt?",
    "answer": "The HER-2/neu oncogene has been found to be amplified in human breast cancer cell lines and primary breast cancers, indicating its potential role in the pathogenesis of breast cancer. Its amplification is associated with a worse prognosis and may have an effect on survival.",
    "ground_truth": "The her-2/neu oncogene is significant in human breast cancer as it has been shown to be amplified in breast cancer cell lines. Specifically, the paper states: 'this gene has been shown to be amplified in human breast cancer cell lines.' This demonstrates that amplification of this oncogene may correlate with disease progression.",
    "source": "'this gene has been shown to be amplified in human breast cancer cell lines.'",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:48:13",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.530519962310791
  },
  {
    "id": 3,
    "repeat_id": 2,
    "question": "What is the significance of the her-2/neu oncogene in human breast cancer as discussed in the excerpt?",
    "answer": "The HER-2/neu oncogene has significant prognostic value in human breast cancer, being equivalent to and independent of the number of positive lymph nodes. Its amplification is associated with a worse prognosis and may have an effect on survival.",
    "ground_truth": "The her-2/neu oncogene is significant in human breast cancer as it has been shown to be amplified in breast cancer cell lines. Specifically, the paper states: 'this gene has been shown to be amplified in human breast cancer cell lines.' This demonstrates that amplification of this oncogene may correlate with disease progression.",
    "source": "'this gene has been shown to be amplified in human breast cancer cell lines.'",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:48:17",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.611524820327759
  },
  {
    "id": 3,
    "repeat_id": 3,
    "question": "What is the significance of the her-2/neu oncogene in human breast cancer as discussed in the excerpt?",
    "answer": "The HER-2/neu oncogene has greater prognostic value than most current factors, including progesterone and estrogen receptors, in human breast cancer. Its amplification is associated with a worse prognosis and may have an effect on survival.",
    "ground_truth": "The her-2/neu oncogene is significant in human breast cancer as it has been shown to be amplified in breast cancer cell lines. Specifically, the paper states: 'this gene has been shown to be amplified in human breast cancer cell lines.' This demonstrates that amplification of this oncogene may correlate with disease progression.",
    "source": "'this gene has been shown to be amplified in human breast cancer cell lines.'",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:48:20",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.660111904144287
  },
  {
    "id": 4,
    "repeat_id": 1,
    "question": "What method was used to analyze alterations in the her - 2 / neu gene in the study?",
    "answer": "The method used to analyze alterations in the HER-2/neu gene in the study was Southern blot analysis, specifically using a 32P-labeled HER-2/neu-1 probe. This allowed researchers to detect any changes or amplifications of the HER-2/neu gene in human breast cancer samples.",
    "ground_truth": "The study utilized Southern blot analysis to evaluate alterations in the her - 2 / neu gene. Specifically, the paper states: 'dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32 p - labeled her - 2 / neu - 1 probe.' This demonstrates that the researchers employed a molecular technique to detect specific genetic alterations.",
    "source": "'dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32 p - labeled her - 2 / neu - 1 probe.'",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:48:24",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.9844424724578857
  },
  {
    "id": 4,
    "repeat_id": 2,
    "question": "What method was used to analyze alterations in the her - 2 / neu gene in the study?",
    "answer": "The method used to analyze alterations in the HER-2/neu gene was Southern blot analysis, which involved digesting DNA with Eco RI and using a 32P-labeled HER-2/neu-1 probe.",
    "ground_truth": "The study utilized Southern blot analysis to evaluate alterations in the her - 2 / neu gene. Specifically, the paper states: 'dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32 p - labeled her - 2 / neu - 1 probe.' This demonstrates that the researchers employed a molecular technique to detect specific genetic alterations.",
    "source": "'dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32 p - labeled her - 2 / neu - 1 probe.'",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:48:28",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.6879613399505615
  },
  {
    "id": 4,
    "repeat_id": 3,
    "question": "What method was used to analyze alterations in the her - 2 / neu gene in the study?",
    "answer": "The method used to analyze alterations in the HER-2/neu gene was Southern blot analysis, using a 32P-labeled HER-2/neu-1 probe after digesting DNA with Eco RI.",
    "ground_truth": "The study utilized Southern blot analysis to evaluate alterations in the her - 2 / neu gene. Specifically, the paper states: 'dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32 p - labeled her - 2 / neu - 1 probe.' This demonstrates that the researchers employed a molecular technique to detect specific genetic alterations.",
    "source": "'dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32 p - labeled her - 2 / neu - 1 probe.'",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:48:32",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.674492835998535
  },
  {
    "id": 5,
    "repeat_id": 1,
    "question": "What specific technique and probe were used to evaluate alterations in the HER-2/neu gene in breast cancer tumors?",
    "answer": "The study used Southern blot analysis as the specific technique, and a 32P-labeled HER-2/neu-1 probe was used to detect any changes or amplifications of the HER-2/neu gene.",
    "ground_truth": "According to the excerpt, Southern blot analysis with a 32P-labeled HER-2/neu-1 probe was used to evaluate alterations in the HER-2/neu gene in breast cancer tumors. Specifically, the paper states: 'dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32p - labeled her - 2 / neu - 1 probe, which is known to detect a 13 - kb hybridizing band in human dna.' This demonstrates that the researchers used a specific molecular biology technique (Southern blot) with a radioactively labeled probe to detect gene amplification in tumor DNA samples.",
    "source": "dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32p - labeled her - 2 / neu - 1 probe, which is known to detect a 13 - kb hybridizing band in human dna.",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:48:35",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.7878341674804688
  },
  {
    "id": 5,
    "repeat_id": 2,
    "question": "What specific technique and probe were used to evaluate alterations in the HER-2/neu gene in breast cancer tumors?",
    "answer": "The study used Southern blot analysis as the specific technique, with a 32P-labeled HER-2/neu-1 probe. This allowed researchers to detect any amplifications of the HER-2/neu gene in human breast cancer samples.",
    "ground_truth": "According to the excerpt, Southern blot analysis with a 32P-labeled HER-2/neu-1 probe was used to evaluate alterations in the HER-2/neu gene in breast cancer tumors. Specifically, the paper states: 'dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32p - labeled her - 2 / neu - 1 probe, which is known to detect a 13 - kb hybridizing band in human dna.' This demonstrates that the researchers used a specific molecular biology technique (Southern blot) with a radioactively labeled probe to detect gene amplification in tumor DNA samples.",
    "source": "dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32p - labeled her - 2 / neu - 1 probe, which is known to detect a 13 - kb hybridizing band in human dna.",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:48:39",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.8677213191986084
  },
  {
    "id": 5,
    "repeat_id": 3,
    "question": "What specific technique and probe were used to evaluate alterations in the HER-2/neu gene in breast cancer tumors?",
    "answer": "The study used Southern blot analysis with a 32P-labeled HER-2/neu-1 probe, which is known to detect a 13-kb hybridizing band in human DNA.",
    "ground_truth": "According to the excerpt, Southern blot analysis with a 32P-labeled HER-2/neu-1 probe was used to evaluate alterations in the HER-2/neu gene in breast cancer tumors. Specifically, the paper states: 'dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32p - labeled her - 2 / neu - 1 probe, which is known to detect a 13 - kb hybridizing band in human dna.' This demonstrates that the researchers used a specific molecular biology technique (Southern blot) with a radioactively labeled probe to detect gene amplification in tumor DNA samples.",
    "source": "dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32p - labeled her - 2 / neu - 1 probe, which is known to detect a 13 - kb hybridizing band in human dna.",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:48:43",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.664830207824707
  },
  {
    "id": 6,
    "repeat_id": 1,
    "question": "What was observed regarding the HER-2/neu loci in the study?",
    "answer": "The study found that some breast cancer samples showed rearrangements in the HER-2/neu gene, and 19 out of 79 tumors had amplification of the HER-2/neu oncogene.",
    "ground_truth": "The study observed that in two of the three cases, the rearrangement of the HER-2/neu loci was identical, and additionally, two of the rearranged HER-2/neu loci were amplified. Specifically, the excerpt states: 'also, two of the rearranged her - 2 / neu loci were amplified.' This indicates a potential significance of these rearrangements in the context of breast cancer.",
    "source": "'also, two of the rearranged her - 2 / neu loci were amplified.'",
    "difficulty": "medium",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:48:46",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.575139284133911
  },
  {
    "id": 6,
    "repeat_id": 2,
    "question": "What was observed regarding the HER-2/neu loci in the study?",
    "answer": "Rearrangements were observed in some breast cancer samples at the HER-2/neu loci, and 19 out of 79 tumors had amplification of the HER-2/neu oncogene.",
    "ground_truth": "The study observed that in two of the three cases, the rearrangement of the HER-2/neu loci was identical, and additionally, two of the rearranged HER-2/neu loci were amplified. Specifically, the excerpt states: 'also, two of the rearranged her - 2 / neu loci were amplified.' This indicates a potential significance of these rearrangements in the context of breast cancer.",
    "source": "'also, two of the rearranged her - 2 / neu loci were amplified.'",
    "difficulty": "medium",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:48:50",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.614502429962158
  },
  {
    "id": 6,
    "repeat_id": 3,
    "question": "What was observed regarding the HER-2/neu loci in the study?",
    "answer": "The study found that some breast cancer samples showed rearrangements in the HER-2/neu gene, and 18% (19 out of 103) had amplification of the HER-2/neu oncogene.",
    "ground_truth": "The study observed that in two of the three cases, the rearrangement of the HER-2/neu loci was identical, and additionally, two of the rearranged HER-2/neu loci were amplified. Specifically, the excerpt states: 'also, two of the rearranged her - 2 / neu loci were amplified.' This indicates a potential significance of these rearrangements in the context of breast cancer.",
    "source": "'also, two of the rearranged her - 2 / neu loci were amplified.'",
    "difficulty": "medium",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:48:54",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.695643424987793
  },
  {
    "id": 7,
    "repeat_id": 1,
    "question": "How do the proteins produced by the HER-2/neu and EGFR genes differ in size?",
    "answer": "The protein encoded by the HER-2/neu gene is 185,000 daltons, while the protein encoded by the EGFR gene is smaller, with no specific size mentioned. However, it can be inferred that they are different sizes since it's stated that HER-2/neu differs from EGFR in this regard.",
    "ground_truth": "According to the excerpt, the protein encoded by the HER-2/neu gene is larger than the protein encoded by the EGFR gene. Specifically, the paper states that the HER-2/neu protein is \"185,000 daltons, as compared to the 170,000-dalton protein encoded by the egfr gene.\"",
    "source": "finally, the protein encoded by the her - 2 / neu gene is 185, 000 daltons, as compared to the 170, 000 - dalton protein encoded by the egfr gene.",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:48:58",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 4.156305313110352
  },
  {
    "id": 7,
    "repeat_id": 2,
    "question": "How do the proteins produced by the HER-2/neu and EGFR genes differ in size?",
    "answer": "The protein encoded by the HER-2/neu gene is 185,000 daltons, while the protein encoded by the EGFR gene is smaller at an unspecified size. However, it's mentioned that they are different sizes.",
    "ground_truth": "According to the excerpt, the protein encoded by the HER-2/neu gene is larger than the protein encoded by the EGFR gene. Specifically, the paper states that the HER-2/neu protein is \"185,000 daltons, as compared to the 170,000-dalton protein encoded by the egfr gene.\"",
    "source": "finally, the protein encoded by the her - 2 / neu gene is 185, 000 daltons, as compared to the 170, 000 - dalton protein encoded by the egfr gene.",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:49:02",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.782048225402832
  },
  {
    "id": 7,
    "repeat_id": 3,
    "question": "How do the proteins produced by the HER-2/neu and EGFR genes differ in size?",
    "answer": "The protein encoded by the HER-2/neu gene is 185,000 daltons, which is larger than the protein encoded by the EGFR gene, which is 170,000 daltons (not explicitly mentioned but inferred from the comparison).",
    "ground_truth": "According to the excerpt, the protein encoded by the HER-2/neu gene is larger than the protein encoded by the EGFR gene. Specifically, the paper states that the HER-2/neu protein is \"185,000 daltons, as compared to the 170,000-dalton protein encoded by the egfr gene.\"",
    "source": "finally, the protein encoded by the her - 2 / neu gene is 185, 000 daltons, as compared to the 170, 000 - dalton protein encoded by the egfr gene.",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:49:06",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.8646063804626465
  },
  {
    "id": 8,
    "repeat_id": 1,
    "question": "What impact does HER-2/neu amplification have on overall survival and relapse in node-positive breast cancer patients according to the excerpt?",
    "answer": "According to the study, amplification of the HER-2/neu gene is a significant predictor of both overall survival and time to relapse in node-positive patients with breast cancer.",
    "ground_truth": "The excerpt indicates that patients with HER-2/neu amplification have significantly different outcomes compared to those without amplification. Specifically, it states: 'the curves dramatically show that patients with her - 2 / neu'. This suggests that higher levels of HER-2/neu amplification correlate with poorer overall survival and increased relapse rates in node-positive patients.",
    "source": "'the curves dramatically show that patients with her - 2 / neu'",
    "difficulty": "easy",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:49:09",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.6308205127716064
  },
  {
    "id": 8,
    "repeat_id": 2,
    "question": "What impact does HER-2/neu amplification have on overall survival and relapse in node-positive breast cancer patients according to the excerpt?",
    "answer": "HER-2/neu amplification is a significant predictor of both poor overall survival and shorter time to relapse in node-positive breast cancer patients.",
    "ground_truth": "The excerpt indicates that patients with HER-2/neu amplification have significantly different outcomes compared to those without amplification. Specifically, it states: 'the curves dramatically show that patients with her - 2 / neu'. This suggests that higher levels of HER-2/neu amplification correlate with poorer overall survival and increased relapse rates in node-positive patients.",
    "source": "'the curves dramatically show that patients with her - 2 / neu'",
    "difficulty": "easy",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:49:13",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.4549310207366943
  },
  {
    "id": 8,
    "repeat_id": 3,
    "question": "What impact does HER-2/neu amplification have on overall survival and relapse in node-positive breast cancer patients according to the excerpt?",
    "answer": "Amplification of the HER-2/neu gene is a significant predictor of both poor overall survival and shorter time to relapse in node-positive patients with breast cancer.",
    "ground_truth": "The excerpt indicates that patients with HER-2/neu amplification have significantly different outcomes compared to those without amplification. Specifically, it states: 'the curves dramatically show that patients with her - 2 / neu'. This suggests that higher levels of HER-2/neu amplification correlate with poorer overall survival and increased relapse rates in node-positive patients.",
    "source": "'the curves dramatically show that patients with her - 2 / neu'",
    "difficulty": "easy",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:49:16",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.519896984100342
  },
  {
    "id": 9,
    "repeat_id": 1,
    "question": "What impact does HER-2/neu gene amplification have on patient outcomes according to the excerpt?",
    "answer": "According to the excerpt, HER-2/neu gene amplification is associated with poor patient outcomes, specifically a shorter overall survival and increased risk of relapse in node-positive breast cancer patients.",
    "ground_truth": "The excerpt indicates that patients with HER-2/neu gene amplification, particularly those with more than 5 copies, had significantly worse outcomes. Specifically, it states: 'patients with greater than five copies of her - 2 / neu had even shorter disease - free survival times (p = 0. 015) and overall survival times (p = 0. 06)'. This demonstrates that higher levels of gene amplification correlate with poorer survival rates.",
    "source": "'patients with greater than five copies of her - 2 / neu had even shorter disease - free survival times (p = 0. 015) and overall survival times (p = 0. 06)'",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:49:20",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.467580556869507
  },
  {
    "id": 9,
    "repeat_id": 2,
    "question": "What impact does HER-2/neu gene amplification have on patient outcomes according to the excerpt?",
    "answer": "HER-2/neu gene amplification is associated with significantly worse patient outcomes, including poorer overall survival and a higher likelihood of relapse in breast cancer patients.",
    "ground_truth": "The excerpt indicates that patients with HER-2/neu gene amplification, particularly those with more than 5 copies, had significantly worse outcomes. Specifically, it states: 'patients with greater than five copies of her - 2 / neu had even shorter disease - free survival times (p = 0. 015) and overall survival times (p = 0. 06)'. This demonstrates that higher levels of gene amplification correlate with poorer survival rates.",
    "source": "'patients with greater than five copies of her - 2 / neu had even shorter disease - free survival times (p = 0. 015) and overall survival times (p = 0. 06)'",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:49:23",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.3864192962646484
  },
  {
    "id": 9,
    "repeat_id": 3,
    "question": "What impact does HER-2/neu gene amplification have on patient outcomes according to the excerpt?",
    "answer": "According to the study, HER-2/neu gene amplification is associated with significantly worse outcomes, including shorter overall survival and increased risk of relapse in breast cancer patients.",
    "ground_truth": "The excerpt indicates that patients with HER-2/neu gene amplification, particularly those with more than 5 copies, had significantly worse outcomes. Specifically, it states: 'patients with greater than five copies of her - 2 / neu had even shorter disease - free survival times (p = 0. 015) and overall survival times (p = 0. 06)'. This demonstrates that higher levels of gene amplification correlate with poorer survival rates.",
    "source": "'patients with greater than five copies of her - 2 / neu had even shorter disease - free survival times (p = 0. 015) and overall survival times (p = 0. 06)'",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:49:26",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.428169012069702
  },
  {
    "id": 10,
    "repeat_id": 1,
    "question": "What types of evidence support the link between proto-oncogenes and human malignancies according to the excerpt?",
    "answer": "The excerpt mentions several lines of evidence that support the link between proto-oncogenes and human malignancies, including: 1) increased expression of specific proto-oncogenes in some human malignancies, 2) localization of proto-oncogenes at or near the site of specific chromosomal translocations associated with tumors, and 3) amplification of proto-oncogenes in some human tumors.",
    "ground_truth": "The excerpt outlines several types of evidence that support the link between proto-oncogenes and human malignancies. It states that this evidence is derived from 'studies of animal models, tumor cell lines, and actual human tumors.' Additionally, it mentions specific data including 'sequence homology between human proto-oncogenes and the viral oncogenes of transforming retroviruses,' 'transfection studies showing the transforming potential of proto-oncogenes in nih 3 t 3 cells and primary embryo fibroblasts,' and 'the central role of certain proto-oncogenes in tumorigen.' This demonstrates that the relationship is supported by both experimental and comparative studies.",
    "source": "'the evidence linking proto - oncogenes to the induction or maintenance of human malignancies is largely circumstantial, but has become increasingly compelling. this circumstantial evidence is derived from studies of animal models, tumor cell lines, and actual human tumors.'",
    "difficulty": "medium",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:49:31",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 4.423877477645874
  },
  {
    "id": 10,
    "repeat_id": 2,
    "question": "What types of evidence support the link between proto-oncogenes and human malignancies according to the excerpt?",
    "answer": "The excerpt mentions several lines of evidence supporting the link between proto-oncogenes and human malignancies, including: sequence homology with viral oncogenes, transfection studies showing transforming potential, increased expression in some cancers, localization near chromosomal translocations, and amplification in some tumors.",
    "ground_truth": "The excerpt outlines several types of evidence that support the link between proto-oncogenes and human malignancies. It states that this evidence is derived from 'studies of animal models, tumor cell lines, and actual human tumors.' Additionally, it mentions specific data including 'sequence homology between human proto-oncogenes and the viral oncogenes of transforming retroviruses,' 'transfection studies showing the transforming potential of proto-oncogenes in nih 3 t 3 cells and primary embryo fibroblasts,' and 'the central role of certain proto-oncogenes in tumorigen.' This demonstrates that the relationship is supported by both experimental and comparative studies.",
    "source": "'the evidence linking proto - oncogenes to the induction or maintenance of human malignancies is largely circumstantial, but has become increasingly compelling. this circumstantial evidence is derived from studies of animal models, tumor cell lines, and actual human tumors.'",
    "difficulty": "medium",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:49:35",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.9650819301605225
  },
  {
    "id": 10,
    "repeat_id": 3,
    "question": "What types of evidence support the link between proto-oncogenes and human malignancies according to the excerpt?",
    "answer": "According to the excerpt, several lines of evidence support the link between proto-oncogenes and human malignancies, including data from animal models, tumor cell lines, and actual human tumors.",
    "ground_truth": "The excerpt outlines several types of evidence that support the link between proto-oncogenes and human malignancies. It states that this evidence is derived from 'studies of animal models, tumor cell lines, and actual human tumors.' Additionally, it mentions specific data including 'sequence homology between human proto-oncogenes and the viral oncogenes of transforming retroviruses,' 'transfection studies showing the transforming potential of proto-oncogenes in nih 3 t 3 cells and primary embryo fibroblasts,' and 'the central role of certain proto-oncogenes in tumorigen.' This demonstrates that the relationship is supported by both experimental and comparative studies.",
    "source": "'the evidence linking proto - oncogenes to the induction or maintenance of human malignancies is largely circumstantial, but has become increasingly compelling. this circumstantial evidence is derived from studies of animal models, tumor cell lines, and actual human tumors.'",
    "difficulty": "medium",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:49:38",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.5116689205169678
  },
  {
    "id": 11,
    "repeat_id": 1,
    "question": "How does HER-2/neu gene amplification impact prognosis in breast cancer patients, and how does its prognostic value compare to other factors?",
    "answer": "According to the excerpt, HER-2/neu gene amplification has greater prognostic value than most currently used prognostic factors, including presence or absence of tumor in axillary nodes, size of primary tumor, and presence or absence of hormonal receptors. It is a significant predictor of both overall survival and time to relapse in node-positive breast cancer patients.",
    "ground_truth": "According to the excerpt, HER-2/neu gene amplification is a significant predictor of both overall survival and time to relapse in breast cancer patients. The study found that it retained its significance even when adjusted for other known prognostic factors. Notably, HER-2/neu amplification showed greater prognostic value than most currently used factors, including hormonal-receptor status, particularly in lymph node-positive disease. This suggests that the HER-2/neu gene may play a crucial role in the biological behavior and/or pathogenesis of human breast cancer.",
    "source": "amplification of the her - 2 / neu gene was a significant predictor of both overall survival and time to relapse in patients with breast cancer. it retained its significance even when adjustments were made for other known prognostic factors. moreover, her - 2 / neu amplification had greater prognostic value than most currently used prognostic factors, including hormonal - receptor status, in lymph node - positive disease. these data indicate that this gene may play a role in the biologic behavior and / or pathogenesis of human breast cancer.",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:49:43",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 4.199460744857788
  },
  {
    "id": 11,
    "repeat_id": 2,
    "question": "How does HER-2/neu gene amplification impact prognosis in breast cancer patients, and how does its prognostic value compare to other factors?",
    "answer": "HER-2/neu gene amplification is a significant predictor of poor prognosis in breast cancer patients, with greater prognostic value than most other factors, including tumor size, node status, and hormonal receptor status.",
    "ground_truth": "According to the excerpt, HER-2/neu gene amplification is a significant predictor of both overall survival and time to relapse in breast cancer patients. The study found that it retained its significance even when adjusted for other known prognostic factors. Notably, HER-2/neu amplification showed greater prognostic value than most currently used factors, including hormonal-receptor status, particularly in lymph node-positive disease. This suggests that the HER-2/neu gene may play a crucial role in the biological behavior and/or pathogenesis of human breast cancer.",
    "source": "amplification of the her - 2 / neu gene was a significant predictor of both overall survival and time to relapse in patients with breast cancer. it retained its significance even when adjustments were made for other known prognostic factors. moreover, her - 2 / neu amplification had greater prognostic value than most currently used prognostic factors, including hormonal - receptor status, in lymph node - positive disease. these data indicate that this gene may play a role in the biologic behavior and / or pathogenesis of human breast cancer.",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:49:46",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.639902114868164
  },
  {
    "id": 11,
    "repeat_id": 3,
    "question": "How does HER-2/neu gene amplification impact prognosis in breast cancer patients, and how does its prognostic value compare to other factors?",
    "answer": "HER-2/neu gene amplification has greater prognostic value than the number of positive lymph nodes and is a significant predictor of poor overall survival and shorter time to relapse in node-positive breast cancer patients.",
    "ground_truth": "According to the excerpt, HER-2/neu gene amplification is a significant predictor of both overall survival and time to relapse in breast cancer patients. The study found that it retained its significance even when adjusted for other known prognostic factors. Notably, HER-2/neu amplification showed greater prognostic value than most currently used factors, including hormonal-receptor status, particularly in lymph node-positive disease. This suggests that the HER-2/neu gene may play a crucial role in the biological behavior and/or pathogenesis of human breast cancer.",
    "source": "amplification of the her - 2 / neu gene was a significant predictor of both overall survival and time to relapse in patients with breast cancer. it retained its significance even when adjustments were made for other known prognostic factors. moreover, her - 2 / neu amplification had greater prognostic value than most currently used prognostic factors, including hormonal - receptor status, in lymph node - positive disease. these data indicate that this gene may play a role in the biologic behavior and / or pathogenesis of human breast cancer.",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:49:50",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.626020669937134
  },
  {
    "id": 12,
    "repeat_id": 1,
    "question": "How does HER-2/neu gene amplification relate to patient prognosis in node-positive breast cancer cases?",
    "answer": "According to the excerpt, HER-2/neu gene amplification is a significant predictor of both overall survival and time to relapse in node-positive breast cancer patients, indicating a poorer prognosis.",
    "ground_truth": "The excerpt indicates that amplification of the HER-2/neu gene is a strong prognostic factor for patients with node-positive breast cancer. Specifically, it states: 'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients.' This demonstrates that HER-2/neu amplification is significant in predicting disease behavior, even when considering other prognostic factors.",
    "source": "'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients, even when other prognostic factors were taken into account'",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:49:53",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.615543842315674
  },
  {
    "id": 12,
    "repeat_id": 2,
    "question": "How does HER-2/neu gene amplification relate to patient prognosis in node-positive breast cancer cases?",
    "answer": "HER-2/neu gene amplification is a significant predictor of poor prognosis in node-positive breast cancer patients, associated with shorter overall survival and increased risk of relapse.",
    "ground_truth": "The excerpt indicates that amplification of the HER-2/neu gene is a strong prognostic factor for patients with node-positive breast cancer. Specifically, it states: 'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients.' This demonstrates that HER-2/neu amplification is significant in predicting disease behavior, even when considering other prognostic factors.",
    "source": "'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients, even when other prognostic factors were taken into account'",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:49:57",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.5092310905456543
  },
  {
    "id": 12,
    "repeat_id": 3,
    "question": "How does HER-2/neu gene amplification relate to patient prognosis in node-positive breast cancer cases?",
    "answer": "HER-2/neu gene amplification is a significant predictor of poor prognosis in node-positive breast cancer patients, retaining its prognostic value even when compared to other factors such as lymph node status.",
    "ground_truth": "The excerpt indicates that amplification of the HER-2/neu gene is a strong prognostic factor for patients with node-positive breast cancer. Specifically, it states: 'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients.' This demonstrates that HER-2/neu amplification is significant in predicting disease behavior, even when considering other prognostic factors.",
    "source": "'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients, even when other prognostic factors were taken into account'",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:50:01",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.6308858394622803
  },
  {
    "id": 13,
    "repeat_id": 1,
    "question": "What is the statistical significance of HER-2/neu as a prognostic factor for relapse in node-positive breast cancer patients according to the multivariate analysis?",
    "answer": "According to the excerpt, HER-2/neu gene amplification retained its significance even when adjustments were made for other known prognostic factors, indicating that it is a strong and independent predictor of poor prognosis.",
    "ground_truth": "According to the multivariate analysis presented in the excerpt, HER-2/neu is a statistically significant prognostic factor for relapse in node-positive breast cancer patients. Specifically, the paper states that HER-2/neu has a p-value of '0.001 (0.1378 \u00b1 0.0425)' for relapse in the multivariate analysis. This demonstrates that HER-2/neu is a strong predictor of disease recurrence, with a highly significant p-value of 0.001.",
    "source": "her - 2 / neu 0. 0011 < 0. 0001 0. 02 ( 0. 0872 \u00b1 0. 0388 ) 0. 001 ( 0. 1378 \u00b1 0. 0425 )",
    "difficulty": "hard",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:50:04",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.8314409255981445
  },
  {
    "id": 13,
    "repeat_id": 2,
    "question": "What is the statistical significance of HER-2/neu as a prognostic factor for relapse in node-positive breast cancer patients according to the multivariate analysis?",
    "answer": "HER-2/neu gene amplification retained its prognostic value with a p-value of 0.99, indicating high statistical significance as a predictor of poor prognosis and increased risk of relapse in node-positive breast cancer patients.",
    "ground_truth": "According to the multivariate analysis presented in the excerpt, HER-2/neu is a statistically significant prognostic factor for relapse in node-positive breast cancer patients. Specifically, the paper states that HER-2/neu has a p-value of '0.001 (0.1378 \u00b1 0.0425)' for relapse in the multivariate analysis. This demonstrates that HER-2/neu is a strong predictor of disease recurrence, with a highly significant p-value of 0.001.",
    "source": "her - 2 / neu 0. 0011 < 0. 0001 0. 02 ( 0. 0872 \u00b1 0. 0388 ) 0. 001 ( 0. 1378 \u00b1 0. 0425 )",
    "difficulty": "hard",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:50:08",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 4.080579996109009
  },
  {
    "id": 13,
    "repeat_id": 3,
    "question": "What is the statistical significance of HER-2/neu as a prognostic factor for relapse in node-positive breast cancer patients according to the multivariate analysis?",
    "answer": "HER-2/neu gene amplification retained its prognostic value, indicating high statistical significance with a p-value not explicitly stated but implied to be significant.",
    "ground_truth": "According to the multivariate analysis presented in the excerpt, HER-2/neu is a statistically significant prognostic factor for relapse in node-positive breast cancer patients. Specifically, the paper states that HER-2/neu has a p-value of '0.001 (0.1378 \u00b1 0.0425)' for relapse in the multivariate analysis. This demonstrates that HER-2/neu is a strong predictor of disease recurrence, with a highly significant p-value of 0.001.",
    "source": "her - 2 / neu 0. 0011 < 0. 0001 0. 02 ( 0. 0872 \u00b1 0. 0388 ) 0. 001 ( 0. 1378 \u00b1 0. 0425 )",
    "difficulty": "hard",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:50:12",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.7962558269500732
  },
  {
    "id": 14,
    "repeat_id": 1,
    "question": "How does HER-2/neu gene amplification relate to patient prognosis in node-positive breast cancer cases?",
    "answer": "According to the excerpt, HER-2/neu gene amplification is a significant predictor of poor prognosis in node-positive breast cancer patients, indicating shorter overall survival and increased risk of relapse.",
    "ground_truth": "The excerpt indicates that amplification of the HER-2/neu gene is a strong prognostic factor in node-positive breast cancer patients. Specifically, it states: 'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients.' This demonstrates that HER-2/neu amplification is significant even when considering other prognostic factors.",
    "source": "'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients'",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:50:16",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.7644131183624268
  },
  {
    "id": 14,
    "repeat_id": 2,
    "question": "How does HER-2/neu gene amplification relate to patient prognosis in node-positive breast cancer cases?",
    "answer": "HER-2/neu gene amplification is a significant predictor of both poor overall survival and shorter time to relapse in node-positive breast cancer patients.",
    "ground_truth": "The excerpt indicates that amplification of the HER-2/neu gene is a strong prognostic factor in node-positive breast cancer patients. Specifically, it states: 'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients.' This demonstrates that HER-2/neu amplification is significant even when considering other prognostic factors.",
    "source": "'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients'",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:50:20",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.510457992553711
  },
  {
    "id": 14,
    "repeat_id": 3,
    "question": "How does HER-2/neu gene amplification relate to patient prognosis in node-positive breast cancer cases?",
    "answer": "HER-2/neu gene amplification is a significant predictor of poor prognosis in node-positive breast cancer patients, retaining its prognostic value even when compared to other factors.",
    "ground_truth": "The excerpt indicates that amplification of the HER-2/neu gene is a strong prognostic factor in node-positive breast cancer patients. Specifically, it states: 'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients.' This demonstrates that HER-2/neu amplification is significant even when considering other prognostic factors.",
    "source": "'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients'",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:50:23",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.5794012546539307
  },
  {
    "id": 15,
    "repeat_id": 1,
    "question": "Based on the comparison of amplification levels for two related tyrosine kinase receptors in human breast cancer, what conclusion does the excerpt draw regarding the generality of gene amplification as a phenomenon in this specific malignancy?",
    "answer": "The excerpt concludes that gene amplification is not a general phenomenon for all related tyrosine kinase-specific receptors in human breast cancer, suggesting that it may be more specific to certain types or subtypes of breast cancer.",
    "ground_truth": "The excerpt concludes that the significant difference in amplification levels between the two related tyrosine kinase receptors suggests that gene amplification is not a universally applicable phenomenon for this class of receptors in human breast cancer. Specifically, the paper states: \"of the former to be 14 times greater than that of the latter, indicating that the phenomenon of gene amplification is not a general one for a related tyrosine kinase - specific receptor in human breast cancer.\"",
    "source": "of the former to be 14 times greater than that of the latter, indicating that the phenomenon of gene amplification is not a general one for a related tyrosine kinase - specific receptor in human breast cancer.",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:50:27",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.974547863006592
  },
  {
    "id": 15,
    "repeat_id": 2,
    "question": "Based on the comparison of amplification levels for two related tyrosine kinase receptors in human breast cancer, what conclusion does the excerpt draw regarding the generality of gene amplification as a phenomenon in this specific malignancy?",
    "answer": "The phenomenon of gene amplification is not a general one for all related tyrosine kinase-specific receptors in human breast cancer, indicating that it may be more specific to certain types or subtypes.",
    "ground_truth": "The excerpt concludes that the significant difference in amplification levels between the two related tyrosine kinase receptors suggests that gene amplification is not a universally applicable phenomenon for this class of receptors in human breast cancer. Specifically, the paper states: \"of the former to be 14 times greater than that of the latter, indicating that the phenomenon of gene amplification is not a general one for a related tyrosine kinase - specific receptor in human breast cancer.\"",
    "source": "of the former to be 14 times greater than that of the latter, indicating that the phenomenon of gene amplification is not a general one for a related tyrosine kinase - specific receptor in human breast cancer.",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:50:31",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.9630727767944336
  },
  {
    "id": 15,
    "repeat_id": 3,
    "question": "Based on the comparison of amplification levels for two related tyrosine kinase receptors in human breast cancer, what conclusion does the excerpt draw regarding the generality of gene amplification as a phenomenon in this specific malignancy?",
    "answer": "The excerpt concludes that gene amplification is not universal among all related tyrosine kinase-specific receptors in human breast cancer, with one receptor showing significantly higher amplification levels than the other.",
    "ground_truth": "The excerpt concludes that the significant difference in amplification levels between the two related tyrosine kinase receptors suggests that gene amplification is not a universally applicable phenomenon for this class of receptors in human breast cancer. Specifically, the paper states: \"of the former to be 14 times greater than that of the latter, indicating that the phenomenon of gene amplification is not a general one for a related tyrosine kinase - specific receptor in human breast cancer.\"",
    "source": "of the former to be 14 times greater than that of the latter, indicating that the phenomenon of gene amplification is not a general one for a related tyrosine kinase - specific receptor in human breast cancer.",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:50:35",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.951798677444458
  },
  {
    "id": 16,
    "repeat_id": 1,
    "question": "What statistical method was used to evaluate the predictive power of prognostic factors in the study?",
    "answer": "The Cox's partial nonparametric regression model and multivariate analysis were used to evaluate the predictive power of prognostic factors in the study.",
    "ground_truth": "The study utilized Cox's partial nonparametric regression model to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner. Specifically, the paper states: 'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.' This demonstrates that the researchers aimed to analyze multiple factors simultaneously to understand their impact on patient outcomes.",
    "source": "'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.'",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:50:38",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.4663405418395996
  },
  {
    "id": 16,
    "repeat_id": 2,
    "question": "What statistical method was used to evaluate the predictive power of prognostic factors in the study?",
    "answer": "Cox's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.",
    "ground_truth": "The study utilized Cox's partial nonparametric regression model to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner. Specifically, the paper states: 'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.' This demonstrates that the researchers aimed to analyze multiple factors simultaneously to understand their impact on patient outcomes.",
    "source": "'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.'",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:50:42",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.475651741027832
  },
  {
    "id": 16,
    "repeat_id": 3,
    "question": "What statistical method was used to evaluate the predictive power of prognostic factors in the study?",
    "answer": "The Cox's partial nonparametric regression model, specifically cox's partial nonparametric regression model, was used to assess the predictive value of prognostic factors.",
    "ground_truth": "The study utilized Cox's partial nonparametric regression model to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner. Specifically, the paper states: 'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.' This demonstrates that the researchers aimed to analyze multiple factors simultaneously to understand their impact on patient outcomes.",
    "source": "'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.'",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:50:45",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.5300991535186768
  },
  {
    "id": 17,
    "repeat_id": 1,
    "question": "Based on the structural description provided in the excerpt for the protein identified as \"[Chunk 8]\", what specific features lead to the inference that it is likely a cellular receptor?",
    "answer": "Sorry, I am allowed to answer questions related to the text only. The term \"[Chunk 8]\" does not appear in the original text. However, based on the description of the protein's structure as having \"tyrosine kinase activity\", it suggests that it may be involved in signal transduction and is likely a cellular receptor.",
    "ground_truth": "According to the excerpt, the inference that the protein \"[Chunk 8]\" is likely a cellular receptor is based on its specific domain structure. The text states: \"[Chunk 8] has an extracellular domain, a transmembrane domain that includes two cysteine - rich repeat clusters, and an intracellular kinase domain, indicating that it too is likely to be a cellular receptor for an as yet unidentified ligand.\" These distinct domains, particularly the extracellular and transmembrane components, are characteristic of receptor proteins.",
    "source": "[Chunk 8] has an extracellular domain, a transmembrane domain that includes two cysteine - rich repeat clusters, and an intracellular kinase domain, indicating that it too is likely to be a cellular receptor for an as yet unidentified ligand.",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:50:50",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 4.2289206981658936
  },
  {
    "id": 17,
    "repeat_id": 2,
    "question": "Based on the structural description provided in the excerpt for the protein identified as \"[Chunk 8]\", what specific features lead to the inference that it is likely a cellular receptor?",
    "answer": "Sorry, I am not able to answer this question as there is no mention of \"[Chunk 8]\" in the original text. However, based on the description of HER-2/neu protein structure and its involvement in tyrosine kinase activity, it suggests that it may be involved in signal transduction and is likely a cellular receptor.",
    "ground_truth": "According to the excerpt, the inference that the protein \"[Chunk 8]\" is likely a cellular receptor is based on its specific domain structure. The text states: \"[Chunk 8] has an extracellular domain, a transmembrane domain that includes two cysteine - rich repeat clusters, and an intracellular kinase domain, indicating that it too is likely to be a cellular receptor for an as yet unidentified ligand.\" These distinct domains, particularly the extracellular and transmembrane components, are characteristic of receptor proteins.",
    "source": "[Chunk 8] has an extracellular domain, a transmembrane domain that includes two cysteine - rich repeat clusters, and an intracellular kinase domain, indicating that it too is likely to be a cellular receptor for an as yet unidentified ligand.",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:50:54",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 4.054263353347778
  },
  {
    "id": 17,
    "repeat_id": 3,
    "question": "Based on the structural description provided in the excerpt for the protein identified as \"[Chunk 8]\", what specific features lead to the inference that it is likely a cellular receptor?",
    "answer": "Sorry, I am not able to answer this question as there is no mention of \"[Chunk 8]\" in the original text. The text actually mentions HER-2/neu and other related tyrosine kinase receptors, but not \"[Chunk 8]\".",
    "ground_truth": "According to the excerpt, the inference that the protein \"[Chunk 8]\" is likely a cellular receptor is based on its specific domain structure. The text states: \"[Chunk 8] has an extracellular domain, a transmembrane domain that includes two cysteine - rich repeat clusters, and an intracellular kinase domain, indicating that it too is likely to be a cellular receptor for an as yet unidentified ligand.\" These distinct domains, particularly the extracellular and transmembrane components, are characteristic of receptor proteins.",
    "source": "[Chunk 8] has an extracellular domain, a transmembrane domain that includes two cysteine - rich repeat clusters, and an intracellular kinase domain, indicating that it too is likely to be a cellular receptor for an as yet unidentified ligand.",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:50:58",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.749455451965332
  },
  {
    "id": 18,
    "repeat_id": 1,
    "question": "What statistical method was used to evaluate the predictive power of prognostic factors in the study?",
    "answer": "Cox's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.",
    "ground_truth": "The study utilized Cox's partial nonparametric regression model to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner. Specifically, the paper states: 'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.' This demonstrates that the researchers aimed to analyze multiple factors simultaneously to understand their impact on patient outcomes.",
    "source": "'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.'",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:51:01",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.2635302543640137
  },
  {
    "id": 18,
    "repeat_id": 2,
    "question": "What statistical method was used to evaluate the predictive power of prognostic factors in the study?",
    "answer": "The Cox's partial nonparametric regression model was used, specifically for evaluating the predictive power of prognostic factors in a multivariate analysis.",
    "ground_truth": "The study utilized Cox's partial nonparametric regression model to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner. Specifically, the paper states: 'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.' This demonstrates that the researchers aimed to analyze multiple factors simultaneously to understand their impact on patient outcomes.",
    "source": "'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.'",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:51:04",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.365602970123291
  },
  {
    "id": 18,
    "repeat_id": 3,
    "question": "What statistical method was used to evaluate the predictive power of prognostic factors in the study?",
    "answer": "Cox's partial nonparametric regression model and multivariate analysis were used to assess the predictive value of various prognostic factors.",
    "ground_truth": "The study utilized Cox's partial nonparametric regression model to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner. Specifically, the paper states: 'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.' This demonstrates that the researchers aimed to analyze multiple factors simultaneously to understand their impact on patient outcomes.",
    "source": "'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.'",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:51:07",
    "model_name": "llama3.1:8b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 3.3158392906188965
  }
]